Correlation Between Morgan Stanley and Biophytis
Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and Biophytis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and Biophytis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Morgan Stanley Direct and Biophytis, you can compare the effects of market volatilities on Morgan Stanley and Biophytis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of Biophytis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and Biophytis.
Diversification Opportunities for Morgan Stanley and Biophytis
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Morgan and Biophytis is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley Direct and Biophytis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biophytis and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley Direct are associated (or correlated) with Biophytis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biophytis has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and Biophytis go up and down completely randomly.
Pair Corralation between Morgan Stanley and Biophytis
Given the investment horizon of 90 days Morgan Stanley Direct is expected to generate 0.16 times more return on investment than Biophytis. However, Morgan Stanley Direct is 6.06 times less risky than Biophytis. It trades about 0.04 of its potential returns per unit of risk. Biophytis is currently generating about -0.04 per unit of risk. If you would invest 1,907 in Morgan Stanley Direct on September 18, 2024 and sell it today you would earn a total of 217.00 from holding Morgan Stanley Direct or generate 11.38% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 60.21% |
Values | Daily Returns |
Morgan Stanley Direct vs. Biophytis
Performance |
Timeline |
Morgan Stanley Direct |
Biophytis |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Morgan Stanley and Biophytis Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Morgan Stanley and Biophytis
The main advantage of trading using opposite Morgan Stanley and Biophytis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, Biophytis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biophytis will offset losses from the drop in Biophytis' long position.Morgan Stanley vs. Equinix | Morgan Stanley vs. Summit Hotel Properties | Morgan Stanley vs. Verde Clean Fuels | Morgan Stanley vs. Nasdaq Inc |
Biophytis vs. NRx Pharmaceuticals | Biophytis vs. NRX Pharmaceuticals | Biophytis vs. Akari Therapeutics PLC | Biophytis vs. Armata Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |